TY - JOUR
T1 - Thromboxane A2 in postischemic acute compartmental syndrome
AU - Dabby, Dan
AU - Greif, Franklin
AU - Yaniv, Moshe
AU - Rubin, Moshe
AU - Dekel, Shmuel
AU - Lelcuk, Shlomo
PY - 1998/9
Y1 - 1998/9
N2 - Objective: To evaluate whether thromboxane A2 participates in the ischemia-reperfusion injury associated with acute compartmental syndrome (ACS) and if by using a cyclooxygenase inhibitor this can be either reduced or abolished. Design: To assess the role of thromboxane A2 in ACS, a tourniquet was applied for 2 hours to the hind limb of 12 dogs. Group 1 (n = 6) served as controls while group 2 (n = 6) was pretreated with lysine- acetyl-salicylate (Lysoprim). Blood thromboxane B2 levels and intracompartmental pressures were assayed prior to inflation of the tourniquet and at 5 minutes, 90 minutes, and 24, 72, and 144 hours after deflation. Results: Five minutes after deflation, the compartmental pressure increased from 11.2 ± 2.2 mm Hg to 16.1 ± 3.3 mm Hg and 17 ± 2.2 mm Hg (mean ± SD) in groups 2 and 1, respectively. At 90 minutes and 24 hours, pressures were 17.1 ± 3.3 mm Hg and 23.2 ± 3.3 mm Hg (P<.01) and 15.3 ± 2.6 mm Hg and 25.2 ± 1.8 mm Hg (mean ± SD) (P<.001), respectively, in groups 2 and 1. A similar effect, although of a lesser magnitude, was observed in the counterlateral limb. Thromboxane B2 levels increased from a mean (± SD) of 46 ± 5.5 pg/0.1 mL to 132 ± 7.5 pg/0.1 mL at 90 minutes in group 1, while remaining unchanged in group 2. Conclusions: Thromboxane A2 plays a major role in the ischemia-reperfusion injury of acute compartmental syndrome. By using a cyclooxygenase inhibitor both the levels of thromboxane and the compartmental pressures can be reduced.
AB - Objective: To evaluate whether thromboxane A2 participates in the ischemia-reperfusion injury associated with acute compartmental syndrome (ACS) and if by using a cyclooxygenase inhibitor this can be either reduced or abolished. Design: To assess the role of thromboxane A2 in ACS, a tourniquet was applied for 2 hours to the hind limb of 12 dogs. Group 1 (n = 6) served as controls while group 2 (n = 6) was pretreated with lysine- acetyl-salicylate (Lysoprim). Blood thromboxane B2 levels and intracompartmental pressures were assayed prior to inflation of the tourniquet and at 5 minutes, 90 minutes, and 24, 72, and 144 hours after deflation. Results: Five minutes after deflation, the compartmental pressure increased from 11.2 ± 2.2 mm Hg to 16.1 ± 3.3 mm Hg and 17 ± 2.2 mm Hg (mean ± SD) in groups 2 and 1, respectively. At 90 minutes and 24 hours, pressures were 17.1 ± 3.3 mm Hg and 23.2 ± 3.3 mm Hg (P<.01) and 15.3 ± 2.6 mm Hg and 25.2 ± 1.8 mm Hg (mean ± SD) (P<.001), respectively, in groups 2 and 1. A similar effect, although of a lesser magnitude, was observed in the counterlateral limb. Thromboxane B2 levels increased from a mean (± SD) of 46 ± 5.5 pg/0.1 mL to 132 ± 7.5 pg/0.1 mL at 90 minutes in group 1, while remaining unchanged in group 2. Conclusions: Thromboxane A2 plays a major role in the ischemia-reperfusion injury of acute compartmental syndrome. By using a cyclooxygenase inhibitor both the levels of thromboxane and the compartmental pressures can be reduced.
UR - http://www.scopus.com/inward/record.url?scp=0031594919&partnerID=8YFLogxK
U2 - 10.1001/archsurg.133.9.953
DO - 10.1001/archsurg.133.9.953
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0031594919
SN - 0004-0010
VL - 133
SP - 953
EP - 956
JO - Archives of Surgery
JF - Archives of Surgery
IS - 9
ER -